Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review

Acquired von Willebrand disease (aVWD) is frequently observed in patients with the need for extracorporeal membrane oxygenation (ECMO). aVWD can be treated by plasma-derived concentrates containing factor VIII (FVIII) and/or von Willebrand factor (VWF) and recombinant VWF concentrate as well as adju...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lars Heubner, Karolin Trautmann-Grill, Oliver Tiebel, Martin Mirus, Andreas Güldner, Axel Rand, Peter Markus Spieth
Formato:	Artigo
Idioma:	Inglês
Publicado:	Georg Thieme Verlag KG 2023-01-01
Series:	TH Open
Assuntos:	acquired coagulation disorders von willebrand disease extracorporal circulation
Acceso en liña:	http://www.thieme-connect.de/DOI/DOI?10.1055/a-2008-4367
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!